Q2  2024 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 18.97% |
600,713 |
0.52 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
16,601 |
0.01 |
Q1  2024 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 11.05% |
198,976 |
0.37 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 81.84% |
74,816 |
0.05 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 3.72% |
122,287 |
0.12 |
Q4  2023 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
91,417 |
0.04 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 6.64% |
233,767 |
0.23 |
Q3  2023 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 18.28% |
402,849 |
0.90 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 3.46% |
126,350 |
0.16 |
Q2  2023 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 9.33% |
188,071 |
0.34 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 722.82% |
3,205,688 |
3.49 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 9.62% |
401,369 |
0.60 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
63,277 |
0.03 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
3,271,319 |
3.77 |
Q1  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 4.23% |
18,000 |
0.15 |
≡ |
Lee Ainslie - Maverick Capital |
Add 294.40% |
47,233 |
0.02 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 4.91% |
215,402 |
0.31 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 2.59% |
86,837 |
0.10 |
Q4  2022 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 6.84% |
129,090 |
0.21 |
≡ |
Mason Hawkins - Longleaf Partners |
Add 14.35% |
550,921 |
0.84 |
≡ |
Lee Ainslie - Maverick Capital |
Add 48.35% |
5,229 |
0.00 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 8.22% |
300,586 |
0.35 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 1.80% |
7,800 |
0.07 |
Q3  2022 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
10,815 |
0.00 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 12.05% |
525,893 |
0.85 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 7.22% |
33,700 |
0.32 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 0.95% |
35,145 |
0.04 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 0.39% |
7,373 |
0.01 |
Q2  2022 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 9.37% |
40,000 |
0.44 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 18.21% |
421,531 |
0.86 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 8.56% |
345,621 |
0.43 |
Q1  2022 |
≡ |
Bill Miller - Miller Value Partners |
Add 0.56% |
22,303 |
0.02 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 5.77% |
23,300 |
0.20 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 19.01% |
1,024,134 |
1.36 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 8.64% |
218,880 |
0.39 |
Q4  2021 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 9.32% |
215,958 |
0.33 |
≡ |
Bill Miller - Miller Value Partners |
Buy |
4,017,205 |
3.06 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 5.28% |
300,419 |
0.39 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
3,654 |
0.00 |
Q3  2021 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 3.61% |
80,759 |
0.11 |
≡ |
Lee Ainslie - Maverick Capital |
Add 54.76% |
1,293 |
0.00 |
Q2  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 46.87% |
2,083 |
0.00 |
Q1  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 34.20% |
2,310 |
0.00 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 9.89% |
245,600 |
0.37 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 3.15% |
184,745 |
0.24 |
Q4  2020 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
6,754 |
0.00 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 29.45% |
2,451,604 |
3.05 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 25.61% |
854,600 |
1.31 |
≡ |
Dodge & Cox |
Sell 100.00% |
7,070,522 |
0.14 |
Q3  2020 |
≡ |
Dodge & Cox |
Reduce 47.14% |
6,305,483 |
0.12 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 12.85% |
491,900 |
0.60 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
304,276 |
0.06 |
Q2  2020 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
304,276 |
0.06 |
Q1  2020 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 38.92% |
1,072,800 |
1.12 |
≡ |
Dodge & Cox |
Reduce 42.22% |
9,772,300 |
0.17 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 16.38% |
1,630,908 |
1.32 |
Q4  2019 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 3.11% |
88,600 |
0.09 |
≡ |
Charles Bobrinskoy - Ariel Focus Fund |
Sell 100.00% |
81,500 |
1.68 |
Q3  2019 |
≡ |
Charles Bobrinskoy - Ariel Focus Fund |
Buy |
81,500 |
1.68 |
Q2  2019 |
≡ |
Dodge & Cox |
Add 4.52% |
1,000,000 |
0.02 |
Q1  2019 |
≡ |
Dodge & Cox |
Add 8.02% |
1,643,804 |
0.03 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 12.29% |
1,395,422 |
0.93 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 11.23% |
359,800 |
0.35 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
202,520 |
0.03 |
Q4  2018 |
≡ |
Mason Hawkins - Longleaf Partners |
Add 2.86% |
315,886 |
0.16 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
202,520 |
0.03 |
Q3  2018 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 10.21% |
296,900 |
0.30 |
≡ |
Thomas Gayner - Markel Group |
Sell 100.00% |
204,000 |
0.06 |
Q2  2018 |
≡ |
Dodge & Cox |
Add 16.71% |
2,935,200 |
0.07 |
≡ |
Thomas Gayner - Markel Group |
Add 106.06% |
105,000 |
0.03 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 5.83% |
180,100 |
0.18 |
Q1  2018 |
≡ |
Dodge & Cox |
Add 5.21% |
869,301 |
0.02 |
≡ |
Thomas Gayner - Markel Group |
Buy |
99,000 |
0.02 |
≡ |
Mason Hawkins - Longleaf Partners |
Reduce 1.58% |
177,426 |
0.09 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Sell 100.00% |
6,625 |
0.00 |
Q4  2017 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 25.07% |
619,000 |
0.58 |
≡ |
Mason Hawkins - Longleaf Partners |
Add 747.21% |
9,889,489 |
6.01 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Buy |
6,625 |
0.00 |
≡ |
Dodge & Cox |
Buy |
16,700,000 |
0.37 |
≡ |
Robert Olstein - Olstein Capital Management |
Sell 100.00% |
539,160 |
1.08 |
Q3  2017 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 30.26% |
573,600 |
0.53 |
≡ |
Robert Olstein - Olstein Capital Management |
Add 375.45% |
425,760 |
0.85 |
≡ |
Mason Hawkins - Longleaf Partners |
Buy |
1,323,524 |
0.85 |
Q2  2017 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 12.81% |
215,200 |
0.27 |
≡ |
Robert Olstein - Olstein Capital Management |
Buy |
113,400 |
0.31 |
Q1  2017 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 4.37% |
70,400 |
0.11 |
Q4  2016 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 10.40% |
151,700 |
0.25 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Sell 100.00% |
6,625 |
0.00 |
Q2  2016 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 8.71% |
139,100 |
0.27 |
≡ |
Thomas Gayner - Markel Group |
Sell 100.00% |
636,000 |
0.57 |
Q1  2016 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Buy |
6,625 |
0.00 |
≡ |
John Rogers - Ariel Appreciation Fund |
Reduce 16.48% |
315,200 |
0.62 |
Q4  2015 |
≡ |
Thomas Gayner - Markel Group |
Add 8.90% |
52,000 |
0.04 |
Q3  2015 |
≡ |
Thomas Gayner - Markel Group |
Add 18.46% |
91,000 |
0.05 |
≡ |
John Rogers - Ariel Appreciation Fund |
Add 133.20% |
1,092,400 |
1.31 |
Q2  2015 |
≡ |
Thomas Gayner - Markel Group |
Add 16.82% |
71,000 |
0.05 |
≡ |
John Rogers - Ariel Appreciation Fund |
Buy |
820,100 |
1.07 |
Q1  2015 |
≡ |
Thomas Gayner - Markel Group |
Add 26.73% |
89,000 |
0.05 |
≡ |
Thomas Russo - Gardner Russo & Quinn |
Sell 100.00% |
6,625 |
0.00 |
Q4  2014 |
≡ |
Thomas Gayner - Markel Group |
Add 16.43% |
47,000 |
0.04 |